265 related articles for article (PubMed ID: 17674155)
21. Analysis of pharmacokinetics of Gd-DTPA for dynamic contrast-enhanced magnetic resonance imaging.
Taheri S; Shah NJ; Rosenberg GA
Magn Reson Imaging; 2016 Sep; 34(7):1034-40. PubMed ID: 27109487
[TBL] [Abstract][Full Text] [Related]
22. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
23. The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI.
Zhang W; Chen Y; Guo DJ; Huang ZW; Cai L; He L
Eur J Radiol; 2011 Sep; 79(3):369-74. PubMed ID: 21106316
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
[TBL] [Abstract][Full Text] [Related]
26. A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism.
Gale EM; Wey HY; Ramsay I; Yen YF; Sosnovik DE; Caravan P
Radiology; 2018 Mar; 286(3):865-872. PubMed ID: 29117483
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of rHA labeled with Gd-DTPA for blood pool imaging and targeted contrast delivery.
Wild JM; Woodrow J; van Beek EJ; Misselwitz B; Johnson R
Contrast Media Mol Imaging; 2010; 5(1):39-43. PubMed ID: 20140975
[TBL] [Abstract][Full Text] [Related]
28. Stability and trapping of magnetic resonance imaging contrast agents during high-intensity focused ultrasound ablation therapy.
Hijnen NM; Elevelt A; Grüll H
Invest Radiol; 2013 Jul; 48(7):517-24. PubMed ID: 23695082
[TBL] [Abstract][Full Text] [Related]
29. Validation of injection parameters for catheter-directed intraarterial gadolinium-enhanced MR angiography.
Omary RA; Henseler KP; Unal O; Smith RJ; Ryu RK; Resnick SA; Saker MB; Chrisman HB; Frayne R; Finn JP; Li D; Grist TM
Acad Radiol; 2002 Feb; 9(2):172-85. PubMed ID: 11918370
[TBL] [Abstract][Full Text] [Related]
30. Dextran gadolinium complexes as contrast agents for magnetic resonance imaging to sentinel lymph nodes.
Yan GP; Xu W; Yang L; Li L; Liu F; Guo QZ
Pharm Res; 2010 Sep; 27(9):1884-92. PubMed ID: 20559699
[TBL] [Abstract][Full Text] [Related]
31. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
32. Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA.
Su MY; Najafi AA; Nalcioglu O
Magn Reson Med; 1995 Sep; 34(3):402-11. PubMed ID: 7500880
[TBL] [Abstract][Full Text] [Related]
33. [Preliminary exploration of Gd-DTPA enhanced inner ear image of guinea pig using magnetic resonance scan].
Dong C; Liu Y; Hua QQ; Lin W; Sun JJ; Huang WN; Liu F; Liu XH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 46(8):669-74. PubMed ID: 22169550
[TBL] [Abstract][Full Text] [Related]
34. Differences in perilymphatic space enhancement and adverse inflammatory reaction after intratympanic injection of two different gadolinium agents: A 9.4-T magnetic resonance imaging study.
Park M; Lee HS; Kim H; Oh SH; Lee JH; Suh MW
Hear Res; 2016 Mar; 333():118-126. PubMed ID: 26795351
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M
Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging.
Port RE; Schuster C; Port CR; Bachert P
Cancer Chemother Pharmacol; 2006 Nov; 58(5):607-17. PubMed ID: 16506037
[TBL] [Abstract][Full Text] [Related]
37. Distribution of intramyocardially injected extracellular MR contrast medium: effects of concentration and volume.
Krombach GA; Baireuther R; Higgins CB; Saeed M
Eur Radiol; 2004 Feb; 14(2):334-40. PubMed ID: 14618368
[TBL] [Abstract][Full Text] [Related]
38. MRI and quantitative autoradiographic studies following bolus injections of unlabeled and (14)C-labeled gadolinium-diethylenetriaminepentaacetic acid in a rat model of stroke yield similar distribution volumes and blood-to-brain influx rate constants.
Nagaraja TN; Ewing JR; Karki K; Jacobs PE; Divine GW; Fenstermacher JD; Patlak CS; Knight RA
NMR Biomed; 2011 Jun; 24(5):547-58. PubMed ID: 21674656
[TBL] [Abstract][Full Text] [Related]
39. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
40. Transferrin-coated gadolinium nanoparticles as MRI contrast agent.
Korkusuz H; Ulbrich K; Welzel K; Koeberle V; Watcharin W; Bahr U; Chernikov V; Knobloch T; Petersen S; Huebner F; Ackermann H; Gelperina S; Kromen W; Hammerstingl R; Haupenthal J; Gruenwald F; Fiehler J; Zeuzem S; Kreuter J; Vogl TJ; Piiper A
Mol Imaging Biol; 2013 Apr; 15(2):148-54. PubMed ID: 22811020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
